Scarica l'app Stockscreener
0.00
100.00%
-63.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTLT Giù?
Forum
Previsione
Precedente Chiudi:
$63.48
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$11.52B
Reddito:
$4.42B
Utile/perdita netta:
$-413.00M
Rapporto P/E:
0.00
EPS:
-1.3
Flusso di cassa netto:
$99.00M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$63.50
Catalent Inc Stock (CTLT) Company Profile
Nome
Catalent Inc
Settore
Telefono
(732) 537-6200
Indirizzo
14 SCHOOLHOUSE ROAD, SOMERSET, NJ
Confronta CTLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTLT
Catalent Inc
|
0.00 | 11.52B | 4.42B | -413.00M | 99.00M | -2.27 |
|
ZTS
Zoetis Inc
|
162.69 | 73.09B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.505 | 42.88B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.20 | 41.75B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.29 | 25.06B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.42 | 14.71B | 15.05B | -883.30M | 1.89B | -0.74 |
Catalent Inc Stock (CTLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-09-05 | Aggiornamento | Argus | Hold → Buy |
| 2023-07-20 | Iniziato | Wells Fargo | Equal Weight |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-06-14 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-05-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-05-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-04-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2023-04-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-11-07 | Downgrade | Argus | Buy → Hold |
| 2022-11-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-16 | Iniziato | Barclays | Overweight |
| 2020-12-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-06-25 | Iniziato | Argus | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-03-02 | Iniziato | Deutsche Bank | Hold |
| 2019-10-17 | Ripresa | Stephens | Overweight |
| 2019-08-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-06-21 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-04-16 | Aggiornamento | UBS | Neutral → Buy |
| 2018-11-07 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-03-28 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-21 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-02-06 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-09-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-13 | Iniziato | Needham | Hold |
| 2017-09-08 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2016-12-01 | Iniziato | Goldman | Neutral |
| 2016-10-20 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-06-21 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-06-20 | Aggiornamento | BofA/Merrill | Neutral → Buy |
Mostra tutto
Catalent Inc Borsa (CTLT) Ultime notizie
Staff AccountantCatalent, Inc. - Built In
Novo Holdings completes purchase of Catalent - MSN
Novo Nordisk Set to Close Catalent Deal Without FTC Challenge - MSN
Novo Holdings completes $16.5 billion takeover of Catalent - MSN
Novo Holdings says its acquisition of Catalent is complete. - The Herald-Times
Catalent, Inc Announces Board Changes - Marketscreener.com
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - MSN
Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent - MSN
Novo Holdings completes Catalent acquisition for $16.5bn - Yahoo Finance
Lennox To Join S&P 500 Index, Replacing Catalent - Yahoo! Voices
This industrials company is joining the S&P 500 soon - MSN
Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business
Novo Completes $16.5 Billion Acquisition of Catalent - Yahoo Finance
Novo Holdings Completes Acquisition of Catalent - citybiz
Novo Holdings Strengthens Pharma Standing With Catalent Acquisition - Finimize
Catalent Acquired by Novo Holdings in $16.5 Billion Deal - TipRanks
Novo Holdings Finalizes $16.5 Billion Acquisition of CatalentNews and Statistics - IndexBox, Inc.
Catalent : Novo Holdings Completes Acquisition of Catalent Form 8 K - Marketscreener.com
Catalent acquired by Novo Holdings for $16.5 billion - Investing.com
Novo Holdings has completed the acquisition of Catalent - Marketscreener.com
The acquisition of Catalent by Novo Holdings, and the - GlobeNewswire
The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed - Yahoo Finance UK
Novo Holdings Completes Massive $16.5B Catalent Acquisition, Offering 47.5% Premium to Shareholders - StockTitan
Novo Nordisk Invests $1.2 Billion in New Denmark Factory, Fresh Off Catalent Deal - geneonline
Catalent wins EU approval for planned $16.5B sale to Novo Holdings - MSN
Novo Nordisk’s New Deal May End Wegovy Shortages. It Could Reshape Pharma Industry Along the Way. - Barron's
Danish pharma giant cleared to buy Catalent - Indiana Public Media
House Panel Accuses Financial Firms of Collusion Over ESG Goals - PYMNTS.com
Novo Holdings Completes Regulatory Hurdles For Catalent Acquisition - Contract Pharma
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle - MM+M Online
Novo Nordisk stock rises following regulatory clearance of Catalent deal - Investing.com
Novo Nordisk stock rises following regulatory clearance of Catalent deal By Investing.com - Investing.com Australia
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction - Marketscreener.com
Novo Nordisk A/S, The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close - Marketscreener.com
Novo Holdings’ purchase of Catalent set to close after regulators’ green light - BioPharma Dive
Catalent (NYSE:CTLT) Sets New 12-Month HighTime to Buy? - MarketBeat
Novo Catalent deal clears regulatory hurdles - BioProcess Insider
Novo Holdings Completes Regulatory Hurdles for Catalent Acquisition - Contract Pharma
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent - Yahoo Finance
Denmark's Novo Nordisk has received FTC approval to acquire three Catalent plants for $11.7 billion - AK&M News
Catalent, Inc. (CTLT) and Novo Holdings A/S Announce Fulfillment of Regulatory Conditions - GuruFocus.com
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition - BioSpace
Catalent : and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction Form 8 K - Marketscreener.com
Novo Holding's purchase of Catalent soon to be completed - Marketscreener.com
Toronto Dominion Bank Lowers Holdings in Catalent, Inc. (NYSE:CTLT) - MarketBeat
Catalent, Inc. (NYSE:CTLT) Shares Sold by Geode Capital Management LLC - MarketBeat
Catalent Inc Azioni (CTLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):